Immunogenic compositions comprising progastrin and uses thereof

The present invention is drawn to immunotherapeutic methods to treat tumors/cancers that produce progastrin ectopically or are dependent on progastrin for their growth. Disclosed herein are immunogenic compositions comprising agents that target progastrin, agents that target the progastrin receptor, annexin II, or both. Such a composition may be administered in combination with chemotherapy or to an individual who had been previously subjected to chemotherapy or radiation therapy. The cancers that may be treated using such a composition may include but are not limited to colon cancer, breast cancer, lung cancer or pancreatic cancer..

Medienart:

Patent

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Europäisches Patentamt - (2019) vom: 02. Juli Zur Gesamtaufnahme - year:2019

Sprache:

Englisch

Beteiligte Personen:

SINGH POMILA [VerfasserIn]
SINGH GURPREET [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
C07K: Peptides (peptides containing β-lactam rings c07d; (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2019-07-02, Last update posted on www.tib.eu: 2024-04-03, Last updated: 2024-04-09

Patentnummer:

US10335470

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA003119254